bioMerieux (OTCMKTS:BMXMF) Upgraded to “Hold” at Zacks Research

Zacks Research upgraded shares of bioMerieux (OTCMKTS:BMXMF) from a strong sell rating to a hold rating in a report published on Monday morning,Zacks reports.

Several other analysts also recently commented on BMXMF. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of bioMerieux in a report on Wednesday, June 17th. UBS Group downgraded bioMerieux from a “buy” rating to a “neutral” rating in a research note on Monday, June 1st. Morgan Stanley restated an “underweight” rating on shares of bioMerieux in a report on Friday, September 11th. Finally, Piper Sandler assumed coverage on bioMerieux in a research report on Thursday, June 11th. They set a “neutral” rating for the company. Five investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Reduce”.

bioMerieux Price Performance

BMXMF stock opened at $83.27 on Monday. The business’s 50-day moving average price is $82.98 and its two-hundred day moving average price is $87.89. The company has a current ratio of 2.39, a quick ratio of 1.48 and a debt-to-equity ratio of 0.08. bioMerieux has a 1-year low of $77.00 and a 1-year high of $138.15.

About bioMerieux

bioMérieux is a France-based healthcare company specializing in in vitro diagnostics. The company develops, manufactures and markets diagnostic systems, reagents and software used to detect infectious diseases, support antimicrobial therapy decisions and assist with disease management.

Its product portfolio includes solutions for microbiology, molecular biology, immunoassays and syndromic testing. bioMérieux’s systems are used by hospitals, clinical laboratories and healthcare providers, while its industrial applications serve the food, pharmaceutical and cosmetics industries by helping customers monitor contamination, quality and safety.

Founded in 1963 by Alain Mérieux, bioMérieux traces its heritage to the Mérieux family’s work in medical diagnostics.